top of page
Browse by category
Search
Journal Watch 26/2/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Ten-year SM-BOSS outcomes: RYGB betters LSG for %EBMIL, GERD and revisions
In this randomized clinical trial, RYGB led to significantly higher %EBMIL in the PP population compared to SG beyond 10 years’...
ReShape signs distribution agreement in Canada with Liaison Medical for its next-generation Lap-Band 2.0 FLEX
ReShape Lifesciences has signed a distribution agreement with Liaison Medical for distribution of ReShape’s next generation, enhanced...
Zoledronic acid increases bone mass in the spine and prevents bone loss in the hip after BMS
A randomised clinical trial (RCT) that investigated the effects of zoledronic acid (ZA) for the prevention of bone loss after Roux-en-Y...
URI study to examine disparities in obesity treatment for Hispanic-Latino communities
Hispanic-Latino individuals experience some of the highest obesity rates in the US compared to other ethnic groups, but have far lower...
Ascletis reveals positive interim results from first two cohorts of MAD study of small molecule oral GLP-1R agonist ASC30
Ascletis Pharma has revealed positive interim results from the first two cohorts of its randomised, double-blind, placebo-controlled...
Browse by tag
bottom of page